Loading…
Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
An acquired V617F JAK2 mutation occurs in patients with polycythemia vera (PV) or essential thrombocythemia (ET). In a proportion of V617F-positive patients, mitotic recombination produces mutation-homozygous cells that come to predominate with time. However, the prevalence of homozygosity is unclea...
Saved in:
Published in: | Blood 2006-10, Vol.108 (7), p.2435-2437 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c436t-2107bf527a46ef1bae3f1991567fc2ef26a6de8b7b6a263a0a1cb754a21e77093 |
---|---|
cites | cdi_FETCH-LOGICAL-c436t-2107bf527a46ef1bae3f1991567fc2ef26a6de8b7b6a263a0a1cb754a21e77093 |
container_end_page | 2437 |
container_issue | 7 |
container_start_page | 2435 |
container_title | Blood |
container_volume | 108 |
creator | Scott, Linda M. Scott, Mike A. Campbell, Peter J. Green, Anthony R. |
description | An acquired V617F JAK2 mutation occurs in patients with polycythemia vera (PV) or essential thrombocythemia (ET). In a proportion of V617F-positive patients, mitotic recombination produces mutation-homozygous cells that come to predominate with time. However, the prevalence of homozygosity is unclear, as previous reports studied mixed populations of wild-type, V617F-heterozygous, and V617F-homozygous mutant cells. We therefore analyzed 1766 individual hematopoietic colonies from 34 patients with PV or ET in whom granulocyte sequencing demonstrated that the mutant peak did not predominate. V617F-positive erythroid burst-forming units (BFU-Es) were more frequent in patients with PV compared with patients with ET (P = .022) and, strikingly, V617F-homozygous BFU-Es were detected in all 17 patients with PV, but in none of the patients with ET (P < .001). Moreover, mutation-homozygous cells were present in 2 patients with ET after polycythemic transformation. These results demonstrate that V617F-homozygous erythroid progenitors are present in most patients with PV but occur rarely in those with ET. |
doi_str_mv | 10.1182/blood-2006-04-018259 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68874860</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120525299</els_id><sourcerecordid>68874860</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-2107bf527a46ef1bae3f1991567fc2ef26a6de8b7b6a263a0a1cb754a21e77093</originalsourceid><addsrcrecordid>eNp9kMGOFCEURYnROD2jf2AMG11Z-qAoqNqYmIkzmkyiC3VLgHpMY6qKFqgx7cJvl7bbzM4VyePcy-MQ8ozBa8Z6_sZOMY4NB5ANiAbqqBsekA3reN8AcHhINnC4FINiZ-Q85-8ATLS8e0zOmFSKSxAb8vtzire4hBJTpts4x1_727hm6mOiZYv0m2Tqis5rMSXEhUbn1kTDQueYC93VIS4l05-hbOkuTnu3r6E5GHqHybyidi10iYVizpULZqqdKc42_uOekEfeTBmfns4L8vXq_ZfLD83Np-uPl-9uGidaWRrOQFnfcWWERM-swdazYWCdVN5x9FwaOWJvlZWGy9aAYc6qThjOUCkY2gvy8ti7S_HHirnoOWSH02QWrN_Vsu-V6CVUUBxBl2LOCb3epTCbtNcM9MG7_utdH7xrEProvcaen_pXO-N4HzqJrsCLE2CyM5NPZnEh33M9k4KLw_tvjxxWG3cBk86uOnY4hoSu6DGG_2_yB6a6o-8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68874860</pqid></control><display><type>article</type><title>Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia</title><source>ScienceDirect (Online service)</source><creator>Scott, Linda M. ; Scott, Mike A. ; Campbell, Peter J. ; Green, Anthony R.</creator><creatorcontrib>Scott, Linda M. ; Scott, Mike A. ; Campbell, Peter J. ; Green, Anthony R.</creatorcontrib><description>An acquired V617F JAK2 mutation occurs in patients with polycythemia vera (PV) or essential thrombocythemia (ET). In a proportion of V617F-positive patients, mitotic recombination produces mutation-homozygous cells that come to predominate with time. However, the prevalence of homozygosity is unclear, as previous reports studied mixed populations of wild-type, V617F-heterozygous, and V617F-homozygous mutant cells. We therefore analyzed 1766 individual hematopoietic colonies from 34 patients with PV or ET in whom granulocyte sequencing demonstrated that the mutant peak did not predominate. V617F-positive erythroid burst-forming units (BFU-Es) were more frequent in patients with PV compared with patients with ET (P = .022) and, strikingly, V617F-homozygous BFU-Es were detected in all 17 patients with PV, but in none of the patients with ET (P < .001). Moreover, mutation-homozygous cells were present in 2 patients with ET after polycythemic transformation. These results demonstrate that V617F-homozygous erythroid progenitors are present in most patients with PV but occur rarely in those with ET.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2006-04-018259</identifier><identifier>PMID: 16772604</identifier><language>eng</language><publisher>Washington, DC: Elsevier Inc</publisher><subject>Base Sequence ; Biological and medical sciences ; Disease Progression ; DNA Mutational Analysis ; Erythroid Precursor Cells - metabolism ; Granulocytes - cytology ; Hematologic and hematopoietic diseases ; Heterozygote ; Homozygote ; Humans ; Janus Kinase 2 ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Medical sciences ; Molecular Sequence Data ; Point Mutation ; Polycythemia Vera - genetics ; Protein-Tyrosine Kinases - genetics ; Protein-Tyrosine Kinases - physiology ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins - physiology ; Stem Cells - cytology ; Thrombocythemia, Essential - genetics</subject><ispartof>Blood, 2006-10, Vol.108 (7), p.2435-2437</ispartof><rights>2006 American Society of Hematology</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-2107bf527a46ef1bae3f1991567fc2ef26a6de8b7b6a263a0a1cb754a21e77093</citedby><cites>FETCH-LOGICAL-c436t-2107bf527a46ef1bae3f1991567fc2ef26a6de8b7b6a263a0a1cb754a21e77093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006497120525299$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18164240$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16772604$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Scott, Linda M.</creatorcontrib><creatorcontrib>Scott, Mike A.</creatorcontrib><creatorcontrib>Campbell, Peter J.</creatorcontrib><creatorcontrib>Green, Anthony R.</creatorcontrib><title>Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia</title><title>Blood</title><addtitle>Blood</addtitle><description>An acquired V617F JAK2 mutation occurs in patients with polycythemia vera (PV) or essential thrombocythemia (ET). In a proportion of V617F-positive patients, mitotic recombination produces mutation-homozygous cells that come to predominate with time. However, the prevalence of homozygosity is unclear, as previous reports studied mixed populations of wild-type, V617F-heterozygous, and V617F-homozygous mutant cells. We therefore analyzed 1766 individual hematopoietic colonies from 34 patients with PV or ET in whom granulocyte sequencing demonstrated that the mutant peak did not predominate. V617F-positive erythroid burst-forming units (BFU-Es) were more frequent in patients with PV compared with patients with ET (P = .022) and, strikingly, V617F-homozygous BFU-Es were detected in all 17 patients with PV, but in none of the patients with ET (P < .001). Moreover, mutation-homozygous cells were present in 2 patients with ET after polycythemic transformation. These results demonstrate that V617F-homozygous erythroid progenitors are present in most patients with PV but occur rarely in those with ET.</description><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Disease Progression</subject><subject>DNA Mutational Analysis</subject><subject>Erythroid Precursor Cells - metabolism</subject><subject>Granulocytes - cytology</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Heterozygote</subject><subject>Homozygote</subject><subject>Humans</subject><subject>Janus Kinase 2</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Medical sciences</subject><subject>Molecular Sequence Data</subject><subject>Point Mutation</subject><subject>Polycythemia Vera - genetics</subject><subject>Protein-Tyrosine Kinases - genetics</subject><subject>Protein-Tyrosine Kinases - physiology</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins - physiology</subject><subject>Stem Cells - cytology</subject><subject>Thrombocythemia, Essential - genetics</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNp9kMGOFCEURYnROD2jf2AMG11Z-qAoqNqYmIkzmkyiC3VLgHpMY6qKFqgx7cJvl7bbzM4VyePcy-MQ8ozBa8Z6_sZOMY4NB5ANiAbqqBsekA3reN8AcHhINnC4FINiZ-Q85-8ATLS8e0zOmFSKSxAb8vtzire4hBJTpts4x1_727hm6mOiZYv0m2Tqis5rMSXEhUbn1kTDQueYC93VIS4l05-hbOkuTnu3r6E5GHqHybyidi10iYVizpULZqqdKc42_uOekEfeTBmfns4L8vXq_ZfLD83Np-uPl-9uGidaWRrOQFnfcWWERM-swdazYWCdVN5x9FwaOWJvlZWGy9aAYc6qThjOUCkY2gvy8ti7S_HHirnoOWSH02QWrN_Vsu-V6CVUUBxBl2LOCb3epTCbtNcM9MG7_utdH7xrEProvcaen_pXO-N4HzqJrsCLE2CyM5NPZnEh33M9k4KLw_tvjxxWG3cBk86uOnY4hoSu6DGG_2_yB6a6o-8</recordid><startdate>20061001</startdate><enddate>20061001</enddate><creator>Scott, Linda M.</creator><creator>Scott, Mike A.</creator><creator>Campbell, Peter J.</creator><creator>Green, Anthony R.</creator><general>Elsevier Inc</general><general>The Americain Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20061001</creationdate><title>Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia</title><author>Scott, Linda M. ; Scott, Mike A. ; Campbell, Peter J. ; Green, Anthony R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-2107bf527a46ef1bae3f1991567fc2ef26a6de8b7b6a263a0a1cb754a21e77093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Disease Progression</topic><topic>DNA Mutational Analysis</topic><topic>Erythroid Precursor Cells - metabolism</topic><topic>Granulocytes - cytology</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Heterozygote</topic><topic>Homozygote</topic><topic>Humans</topic><topic>Janus Kinase 2</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Medical sciences</topic><topic>Molecular Sequence Data</topic><topic>Point Mutation</topic><topic>Polycythemia Vera - genetics</topic><topic>Protein-Tyrosine Kinases - genetics</topic><topic>Protein-Tyrosine Kinases - physiology</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins - physiology</topic><topic>Stem Cells - cytology</topic><topic>Thrombocythemia, Essential - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Scott, Linda M.</creatorcontrib><creatorcontrib>Scott, Mike A.</creatorcontrib><creatorcontrib>Campbell, Peter J.</creatorcontrib><creatorcontrib>Green, Anthony R.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Scott, Linda M.</au><au>Scott, Mike A.</au><au>Campbell, Peter J.</au><au>Green, Anthony R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2006-10-01</date><risdate>2006</risdate><volume>108</volume><issue>7</issue><spage>2435</spage><epage>2437</epage><pages>2435-2437</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>An acquired V617F JAK2 mutation occurs in patients with polycythemia vera (PV) or essential thrombocythemia (ET). In a proportion of V617F-positive patients, mitotic recombination produces mutation-homozygous cells that come to predominate with time. However, the prevalence of homozygosity is unclear, as previous reports studied mixed populations of wild-type, V617F-heterozygous, and V617F-homozygous mutant cells. We therefore analyzed 1766 individual hematopoietic colonies from 34 patients with PV or ET in whom granulocyte sequencing demonstrated that the mutant peak did not predominate. V617F-positive erythroid burst-forming units (BFU-Es) were more frequent in patients with PV compared with patients with ET (P = .022) and, strikingly, V617F-homozygous BFU-Es were detected in all 17 patients with PV, but in none of the patients with ET (P < .001). Moreover, mutation-homozygous cells were present in 2 patients with ET after polycythemic transformation. These results demonstrate that V617F-homozygous erythroid progenitors are present in most patients with PV but occur rarely in those with ET.</abstract><cop>Washington, DC</cop><pub>Elsevier Inc</pub><pmid>16772604</pmid><doi>10.1182/blood-2006-04-018259</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-4971 |
ispartof | Blood, 2006-10, Vol.108 (7), p.2435-2437 |
issn | 0006-4971 1528-0020 |
language | eng |
recordid | cdi_proquest_miscellaneous_68874860 |
source | ScienceDirect (Online service) |
subjects | Base Sequence Biological and medical sciences Disease Progression DNA Mutational Analysis Erythroid Precursor Cells - metabolism Granulocytes - cytology Hematologic and hematopoietic diseases Heterozygote Homozygote Humans Janus Kinase 2 Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Medical sciences Molecular Sequence Data Point Mutation Polycythemia Vera - genetics Protein-Tyrosine Kinases - genetics Protein-Tyrosine Kinases - physiology Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins - physiology Stem Cells - cytology Thrombocythemia, Essential - genetics |
title | Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T10%3A18%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Progenitors%20homozygous%20for%20the%20V617F%20mutation%20occur%20in%20most%20patients%20with%20polycythemia%20vera,%20but%20not%20essential%20thrombocythemia&rft.jtitle=Blood&rft.au=Scott,%20Linda%20M.&rft.date=2006-10-01&rft.volume=108&rft.issue=7&rft.spage=2435&rft.epage=2437&rft.pages=2435-2437&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2006-04-018259&rft_dat=%3Cproquest_cross%3E68874860%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c436t-2107bf527a46ef1bae3f1991567fc2ef26a6de8b7b6a263a0a1cb754a21e77093%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68874860&rft_id=info:pmid/16772604&rfr_iscdi=true |